The analysis of human papillomavirus DNA in penile cancer tissue by in situ hybridization

Takamoto,Daiji; Kawahara,Takashi; Kasuga,Jun; Sasaki,Takeshi; Yao,Masahiro; Yumura,Yasushi; Uemura,Hiroji

doi:10.3892/ol.2018.8351

The analysis of human papillomavirus DNA in penile cancer tissue by in situ hybridization

Authors:
- Daiji Takamoto
- Takashi Kawahara
- Jun Kasuga
- Takeshi Sasaki
- Masahiro Yao
- Yasushi Yumura
- Hiroji Uemura
View Affiliations

Affiliations: Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Kanagawa 2360004, Japan, Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Kanagawa 2360004, Japan, Department of Hospital Coordinate Promotion and Telepathology, Tokyo University Hospital, Tokyo 1138655, Japan, Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 2320024, Japan
Published online on: March 26, 2018 https://doi.org/10.3892/ol.2018.8351
Pages: 8102-8106

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Primary penile cancer is a rare disease. Higher incidence rates occur in underdeveloped countries. Many studies have suggested an association between human papillomavirus (HPV) infection and penile cancer. Although HPV can affect the squamous epithelium of the male genitalia similarly to the female genital tract, the association between penile cancer and HPV remains unclear. In the present study, the HPV gene expression was examined in penile cancer tissue using in situ hybridization (ISH). The present study included 41 cases in which penectomy was performed and 3 cases in which tumor resection was performed to treat pathologically‑diagnosed penile cancer at Yokohama City University Medical Center, and its 7 affiliated hospitals between April 1990 and March 2010. The penile cancer tissue was subjected to an ISH analysis, and the clinicopathological features and prognosis were investigated. A total of 5/44 cases (11.4%) showed the expression of high‑risk HPV. None of the patients showed the expression of low‑risk HPV. The associations between the expression of high‑risk HPV, and age, tumor location, tumor size, T stage, pathological differentiation, nuclear grade, Broder's classification, pattern of invasion, Y‑K grade, vascular invasion, lymphoid invasion, koilocytosis and lymph‑node metastasis were then examined. Patients with a well‑differentiated status (P=0.044) and Broder's Grade 1 (P=0.019) showed a significantly lower rate of HPV positivity. The HPV expression was not significantly associated with cancer specific survival (P=0.932). ISH using INFORM HPV III does not detect the HPV genotype, this method is easy to employ and may be useful for the diagnosis of penile cancer tissue, similarly to cervical cancer.

View Figures

View References

1	Lu B, Wu Y, Nielson CM, Flores R, Abrahamsen M, Papenfuss M, Harris RB and Giuliano AR: Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: A prospective study. J Infect Dis. 199:362–371. 2009. View Article : Google Scholar : PubMed/NCBI
2	da Costa WH, de Oliveira Rosa RA, Santana TB, Benigno BS, da Cunha IW, de Cássio Zequi S, Guimaraes GC and Lopes A: Prognostic factors in patients with penile carcinoma and inguinal lymph node metastasis. Int J Urol. 22:669–673. 2015. View Article : Google Scholar : PubMed/NCBI
3	Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J and Meijer CJ: Penile cancer: Epidemiology, pathogenesis and prevention. World J Urol. 27:141–150. 2009. View Article : Google Scholar : PubMed/NCBI
4	Iwasawa A, Kumamoto Y and Fujinaga K: Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol. 149:59–63. 1993. View Article : Google Scholar : PubMed/NCBI
5	Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, Markowitz LE, Smith D and Harris RB: The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: The HPV detection in men study. J Infect Dis. 196:1146–1152. 2007. View Article : Google Scholar : PubMed/NCBI
6	Nielson CM, Flores R, Harris RB, Abrahamsen M, Papenfuss MR, Dunne EF, Markowitz LE and Giuliano AR: Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev. 16:1107–1114. 2007. View Article : Google Scholar : PubMed/NCBI
7	Rombaldi RL, Serafini EP, Villa LL, Vanni AC, Baréa F, Frassini R, Xavier M and Paesi S: Infection with human papillomaviruses of sexual partners of women having cervical intraepithelial neoplasia. Braz J Med Biol Res. 39:177–187. 2006. View Article : Google Scholar : PubMed/NCBI
8	Cohen C, Lawson D, Jiang J and Siddiqui MT: Automated in situ hybridization for human papilloma virus. Appl Immunohistochem Mol Morphol. 22:619–622. 2014. View Article : Google Scholar : PubMed/NCBI
9	Lodde M, Mian C, Mayr R, Comploj E, Trenti E, Melotti R, Campodonico F, Maffezzini M, Fritsche HM and Pycha A: Recurrence and progression in patients with non-muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading. Int J Urol. 21:968–972. 2014. View Article : Google Scholar : PubMed/NCBI
10	Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS and Ramaekers FC: HPV in situ hybridization: Impact of different protocols on the detection of integrated HPV. Int J Cancer. 115:419–428. 2005. View Article : Google Scholar : PubMed/NCBI
11	Pirog EC: Immunohistochemistry and in situ hybridization for the diagnosis and classification of squamous lesions of the anogenital region. Semin Diagn Pathol. 32:409–418. 2015. View Article : Google Scholar : PubMed/NCBI
12	Ishida M, Ohashi S, Kizaki Y, Naito J, Horiguchi K and Harigaya T: Expression profiling of mouse placental lactogen II and its correlative genes using a cDNA microarray analysis in the developmental mouse placenta. J Reprod Dev. 53:69–76. 2007. View Article : Google Scholar : PubMed/NCBI
13	Stratton KL and Culkin DJ: A contemporary review of HPV and penile cancer. Oncology (Williston Park). 30:245–249. 2016.PubMed/NCBI
14	Weaver MG, Abdul-Karim FW, Dale G, Sorensen K and Huang YT: Detection and localization of human papillomavirus in penile condylomas and squamous cell carcinomas using in situ hybridization with biotinylated DNA viral probes. Mod Pathol. 2:94–100. 1989.PubMed/NCBI
15	Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Eckel HE, Pfister HJ and Fuchs PG: Human papillomavirus-positive tonsillar carcinomas: A different tumor entity? Med Microbiol Immunol. 192:129–132. 2003. View Article : Google Scholar : PubMed/NCBI
16	Lont AP, Kroon BK, Horenblas S, Gallee MP, Berkhof J, Meijer CJ and Snijders PJ: Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 119:1078–1081. 2006. View Article : Google Scholar : PubMed/NCBI
17	Bezerra AL, Lopes A, Santiago GH, Ribeiro KC, Latorre MR and Villa LL: Human papillomavirus as a prognostic factor in carcinoma of the penis: Analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 91:2315–2321. 2001. View Article : Google Scholar : PubMed/NCBI
18	Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 92:709–720. 2000. View Article : Google Scholar : PubMed/NCBI
19	Li W, Thompson CH, Xin D, Cossart YE, O'Brien CJ, McNeil EB, Gao K, Scolyer RA and Rose BR: Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol. 163:2185–2189. 2003. View Article : Google Scholar : PubMed/NCBI
20	Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP and Haugen TH: Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 104:336–344. 2003. View Article : Google Scholar : PubMed/NCBI
21	Ansink AC, Krul MR, De Weger RA, Kleyne JA, Pijpers H, Van Tinteren H, De Kraker EW, Helmerhorst TJ and Heintz AP: Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: Detection and prognostic significance. Gynecol Oncol. 52:180–184. 1994. View Article : Google Scholar : PubMed/NCBI
22	Bosch FX, Muñoz N and de Sanjosé S: Human papillomavirus and other risk factors for cervical cancer. Biomed Pharmacother. 51:268–275. 1997. View Article : Google Scholar : PubMed/NCBI
23	ter Harmsel B, Smedts F, Kuijpers J, van Muyden R, Oosterhuis W and Quint W: Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia. Obstet Gynecol. 93:46–50. 1999. View Article : Google Scholar : PubMed/NCBI
24	Wiener JS, Effert PJ, Humphrey PA, Yu L, Liu ET and Walther PJ: Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: A retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int J Cancer. 50:694–701. 1992. View Article : Google Scholar : PubMed/NCBI
25	Senba M, Kumatori A, Fujita S, Jutavijittum P, Yousukh A, Moriuchi T, Nakamura T and Toriyama K: The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol. 78:1341–1346. 2006. View Article : Google Scholar : PubMed/NCBI
26	Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ: International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
27	Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N and Fujita Y: High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res. 53:4823–4827. 1993.PubMed/NCBI
28	Philippou P, Shabbir M, Ralph DJ, Malone P, Nigam R, Freeman A, Muneer A and Minhas S: Genital lichen sclerosus/balanitis xerotica obliterans in men with penile carcinoma: A critical analysis. BJU Int. 111:970–976. 2013. View Article : Google Scholar : PubMed/NCBI
29	D'Hauwers KW, Depuydt CE, Bogers JJ, Noel JC, Delvenne P, Marbaix E, Donders AR and Tjalma WA: Human papillomavirus, lichen sclerosus and penile cancer: A study in Belgium. Vaccine. 30:6573–6577. 2012. View Article : Google Scholar : PubMed/NCBI
30	Newman PA, Logie CH, Doukas N and Asakura K: HPV vaccine acceptability among men: A systematic review and meta-analysis. Sex Transm Infect. 89:568–574. 2013. View Article : Google Scholar : PubMed/NCBI
31	Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K and Hickman M: Inequalities in the uptake of human papillomavirus vaccination: A systematic review and meta-analysis. Int J Epidemiol. 42:896–908. 2013. View Article : Google Scholar : PubMed/NCBI
32	Sonpavde G, Pagliaro LC, Buonerba C, Dorff TB, Lee RJ and Di Lorenzo G: Penile cancer: Current therapy and future directions. Ann Oncol. 24:1179–1189. 2013. View Article : Google Scholar : PubMed/NCBI